These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 865646)

  • 21. Combination therapy: some concepts and results.
    Skipper HE
    Cancer Chemother Rep 2; 1974 Mar; 4(1):137-45. PubMed ID: 4363649
    [No Abstract]   [Full Text] [Related]  

  • 22. The sensitivity testing of Wilms' tumors to cytostatic agents with an autoradiographic in vitro short-term test.
    Willnow U
    Neoplasma; 1984; 31(6):719-26. PubMed ID: 6097829
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The potential for enhancing the therapeutic efficacy of antitumor preparations].
    Konovalova NP; Volkova LM; Klochko AV
    Izv Akad Nauk SSSR Biol; 1989; (3):466-8. PubMed ID: 2760333
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antitumor action of pyran copolymer and tilorone against Lewis lung carcinoma and B-16 melanoma.
    Morahan PS; Munson JA; Baird LG; Kaplan AM; Regelson W
    Cancer Res; 1974 Mar; 34(3):506-11. PubMed ID: 4812258
    [No Abstract]   [Full Text] [Related]  

  • 25. Some aspects of the use of cytostatic drugs in dermatology.
    Falkson G
    S Afr Med J; 1966 Apr; 40(15):339-42. PubMed ID: 4160603
    [No Abstract]   [Full Text] [Related]  

  • 26. Consideration of the subcutaneously implanted B16 melanoma as a screening model for potential anticancer agents.
    Griswold DP
    Cancer Chemother Rep 2; 1972 Nov; 3(1):315-24. PubMed ID: 4660734
    [No Abstract]   [Full Text] [Related]  

  • 27. [Effect of 1,4-benzoquinone-guanylhydrazone-thiosemicarbazone on B-16 melanoma in the mouse and AMel 3 melanoma in the hamster].
    Gutsche W; Wohlrab W
    Dermatol Monatsschr; 1983; 169(8):509-13. PubMed ID: 6628786
    [No Abstract]   [Full Text] [Related]  

  • 28. The screening test of various chemotherapeutic drugs in primary malignant melanoma cells and human malignant melanoma cell line (TM-1).
    Kuriya Y; Nishihira T; Mori S; Watanabe T; Kasai M
    Tohoku J Exp Med; 1979 Jul; 128(3):209-16. PubMed ID: 494243
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Approaches to combination chemotherapy in rat, mouse, and hamster tumors.
    Griswold DP; Dykes DJ; Kelley CA; Roberts BJ; Dominick CA
    Cancer Chemother Rep 2; 1974 Mar; 4(1):99-108. PubMed ID: 4524043
    [No Abstract]   [Full Text] [Related]  

  • 30. [Pretherapeutic testing of sensitivity to cytostatic drugs in primary cultures of selected urologic tumors].
    Klatte D; Redmann K; Müller GW; Richter A; Gabriel D
    Z Urol Nephrol; 1986 Aug; 79(8):441-7. PubMed ID: 2430377
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Morphologic characteristics of Harding-Passy melanoma during treatment with endoxan and serotonin].
    Man'ko IuK; Iushkov SF
    Arkh Patol; 1968; 30(10):26-31. PubMed ID: 5727370
    [No Abstract]   [Full Text] [Related]  

  • 32. [Introduction of new screening system in National Cancer Institute].
    Tsukagoshi S
    Gan To Kagaku Ryoho; 1984 May; 11(5):1134-9. PubMed ID: 6539100
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of various immunosuppressive drugs on experimental allergic encephalomyelitis in chickens.
    Blaszczyk B; Karakoz I; Gieldanowski J
    Folia Biol (Praha); 1977; 23(6):398-9. PubMed ID: 608476
    [No Abstract]   [Full Text] [Related]  

  • 34. Growth inhibition by chemotherapeutic agents on stilbestrol-induced hamster kidney tumor.
    DeKernion JB; Resnick MI; Persky L
    Surg Forum; 1971; 22():514-6. PubMed ID: 4256349
    [No Abstract]   [Full Text] [Related]  

  • 35. Effectiveness of anticancer drugs determined in nude mice inoculated with [125I]5-iodo-2'-deoxyuridine-prelabeled human melanoma cells.
    Lockshin A; Giovanella BC; Vardeman DM; Mendoza JT; Quian C; Kozielski T; Stehlin JS
    J Natl Cancer Inst; 1985 Apr; 74(4):899-903. PubMed ID: 3921748
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The combined action of 2,5,6-H3-DOPA and alkylating agents on Harding-Passy melanoma].
    Ivanov II; Vdovenko VM; Bobrova VN; Gavrilenko IS; Rumiantseva LN
    Vopr Onkol; 1972; 18(8):76-80. PubMed ID: 4657683
    [No Abstract]   [Full Text] [Related]  

  • 37. [Adjuvant interferon treatment of melanoma].
    Török L
    Magy Onkol; 2003; 47(1):105-7. PubMed ID: 12704462
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship between modulation of natural killer cell activity and antitumor activity of bropirimine when used in combination with various types of chemotherapeutic drugs.
    Li LH; DeKoning TF; Wallace TL
    Cancer Res; 1987 Nov; 47(22):5894-900. PubMed ID: 3664490
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chemo- and immunotherapy of an adenovirus-induced transplantable sarcoma in hamsters.
    Todorov DK; Silyanovska KK; Maneva KM; Ilarionova MV; Gantchev GT; Getov CM
    Neoplasma; 1987; 34(3):287-94. PubMed ID: 3039387
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effect of a new benzodiazepine derivative on experimental malignant melanomas].
    Werner W; Wohlrabe K; Fichtner I; Wohlrab W
    Arch Geschwulstforsch; 1987; 57(1):17-23. PubMed ID: 3566461
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.